Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Chlorothiazide 38mg/5ml oral suspension
0202010D0AADCDC
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 40mg/5ml oral liquid
0202010D0AABHBH
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 47mg/5ml oral liquid
0202010D0AACTCT
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 500mg tablets
0202010D0AAAFAF
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 500mg/5ml oral liquid
0202010D0AABVBV
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 50mg/5ml oral suspension
0202010D0AABFBF
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 5mg/5ml oral liquid
0202010D0AACGCG
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 60mg/5ml oral suspension
0202010D0AACNCN
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 6mg/5ml oral liquid
0202010D0AABNBN
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 7.5mg/5ml oral liquid
0202010D0AACKCK
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 70mg/5ml oral liquid
0202010D0AABGBG
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 750mg/5ml oral liquid
0202010D0AACMCM
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 75mg/5ml oral liquid
0202010D0AACBCB
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 80mg/5ml oral suspension
0202010D0AABTBT
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 85mg/5ml oral liquid
0202010D0AACECE
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 90mg/5ml oral liquid
0202010D0AACHCH
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorphenamine 50mg/5ml oral solution
0304010G0AAALAL
|
Chlorphenamine maleate | Chlorphenamine maleate | Respiratory System | No data available |
|
Chlorpromazine 1.5mg/5ml oral liquid
0402010D0AABABA
|
Chlorpromazine hydrochloride | Chlorpromazine hydrochloride | Central Nervous System | No data available |
|
Chlorpromazine 100mg suppositories
0402010D0AAARAR
|
Chlorpromazine hydrochloride | Chlorpromazine hydrochloride | Central Nervous System | No data available |
|
Chlorpromazine 100mg/5ml oral suspension sugar free
0402010D0AAAPAP
|
Chlorpromazine hydrochloride | Chlorpromazine hydrochloride | Central Nervous System | No data available |
|
Chlorpromazine 10mg/5ml oral liquid
0402010D0AAA6A6
|
Chlorpromazine hydrochloride | Chlorpromazine hydrochloride | Central Nervous System | No data available |
|
Chlorpromazine 12.5mg/5ml oral liquid
0402010D0AABBBB
|
Chlorpromazine hydrochloride | Chlorpromazine hydrochloride | Central Nervous System | No data available |
|
Chlorpromazine 25mg suppositories
0402010D0AAASAS
|
Chlorpromazine hydrochloride | Chlorpromazine hydrochloride | Central Nervous System | No data available |
|
Chlorpromazine 25mg/1ml solution for injection ampoules
0402010D0AAADAD
|
Chlorpromazine hydrochloride | Chlorpromazine hydrochloride | Central Nervous System | No data available |
|
Chlorpromazine 50mg/2ml solution for injection ampoules
0402010D0AAAMAM
|
Chlorpromazine hydrochloride | Chlorpromazine hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.